Enveric corrects proxy error: reverse split ratio range is 1-for-5 to 1-for-15, not 1-for-50

Enveric Biosciences, Inc.

Corrected reverse split range from erroneously stated 1-for-50 to correct 1-for-15 in proxy statement.
Error appeared on proxy card and notice of internet availability; other proposal text was correct.
Meeting details (May 28, 2026, virtual, all proposals) remain unchanged; supplemental filing made April 30.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.